Kintor has started Phase 3 trial in China for Pyrilutamide
- Thread starter Micky_007
- Start date
- Reaction score
- 179
where do you live? its tempting but I wouldn't use it in the next half year probably and then it'll get bad
- Reaction score
- 64
A life without libido is true freedom
but people start to question my sexual orientation
- Reaction score
- 764
Same here, I was having chest pain and as a test I stopped all use of pyri, the chest pain went away and came back when I resumed it. My sex drive and performance massively decreased as well. IDK if this is something specific to MinoxidilMax's version, when the official one comes out I'll try that.
- Reaction score
- 497
Last time I cycled off it took 8 days to get back to my usual libido.
I advise you to change the bed and pillow sheets because it accumulates there most likely.
Too bad the most effective drug that I ever used againt Androgenetic Alopecia also makes me forget that I have a dick.
i don’t have heart related side effects anymore, I had them for a few weeks then they went away for good
I’m back on it for a while because I have an important encounter with some people I know. Later I’m definitely giving CB a serious try but obviously it is not as strong as pyri because it doesn’t stop the itch
Hi @Min0, why you say "I’m back on it for a while because I have an important encounter with some people I know"? I don't understand. Are you using Pyri again? It is going to give you a heart attack.
@DAVAT yes, I reduced the dosage at minimum. I was trying to find a balance during 2 weeks, but even a 0,25% once per day, I couldn't sleep properly because I couldn't relax due to strong cardiac arrhythmias.
What I'm noticing a lot on Reddit is that people who don't get side effects from it don't get better hair, but those who do get side effects from it, it helps to recover hair.
I am with @RU serious, maybe the original from Kintor is better from Actifolic or MinoxidilMax. But anyway, the Pyrilutamide blood concentration in Kintor results was 0,5ng/ml, same as my last DHT level. And that is pretty bad. Not a good signal at all.
can you explain the last thing you say about your dht levels? what does it have to do with the piry concentration of 0.5/ml?
- Reaction score
- 497
I don’t have heart side effects at low doses
I don't know who you're going to meet with, but people don't care about you at all. People only care about themselves.
Well, I have 2 unopened bottles of Pyrilutamide at 0,5%. If someone want it, I will offer half price and also the proof of order from Actifolic. 30€ per bottle. Transport included. 1 year of shelf life.
- Reaction score
- 892
I suspect if we could get our hands on a good liposomal vehicle it might be okay:
I just wish this was easier said than done.
I just wish this was easier said than done.
in fact it is
It means that the DHT blood levels are in the same amount as the pyrilutamide levels. Taking into account that Pyrilutamide has a higher affinity for the androgen receptor than DHT itself, it means that Kintor's own results already show how pyrilutamide blocks 100% of the DHT in your body, which makes it very dangerous. Therefore, the hope that Kintor is using a better vehicle than Actifolic is zero.
Kintor Pharma Raises $65 Million For Drug Commercialization
Kintor Pharmaceutical Ltd. announced on Sunday that it will place 42 million shares, representing approximately 10.3% of its enlarged capital after the issue.
seekingalpha.com
The money will be used for development and commercialization for Proxalutamide, Pyri and Protac drug.
- Reaction score
- 179
it is in fact pretty easy to make a basic liposomal vehicle. the problem is however that liposomal is not that great either and depending on particle size(refer to figure 3 in the paper at the bottom), zeta potential or charge of the particles, loaded drug and its interactions with the particle all have a drastic influence on how it behaves. there is lots of research on this topic from in vitro and animal studies. for example for a liposomal additional excipients and size of the particles(should not be too big or small) have a major impact on how it behaves in the skin. one carrier that works for finasteride might not work for pyrilutamide due to molecule size, if they are lipohile or not etc.
ive been saying this for half a year, people here are sleeping on the idea of better delivery with a targeted vehicle. thats the future. maintenance drugs will all be anti androgenic in nature and carry the potential for systemic sexual side effects. furthermore they are not as effective on the scalp as they could be if they accumulated there. additionally new treatments from different angles won't be here for many years. I am mostly interested in what hutera from Korea or Japan is doing with their patented nanostructure lipid carrier that promises to deliver dutasteride right down the hair shaft and release it there with little systemic concentrations. this carrier could be used for other anti androgenic drugs as well. I recall a study that showed 7 times more minoxidil accumulation in the hair follicle as opposed to a standard vehicle with less transdermal(we dont want this) flux. this kind of carrier would allow using 7 times less drug to have the same local effect. additionally is has less transdermal flux so you use less and additionally less goes systemic.
but people aren't interested in this kind of stuff, most certainly big Pharma is not interested in better delivery of existing drugs because how could they make additional money off of it? they cannot. and so the research is super slow but I think it is quite promising. it also seems to have picked up in recent years based on paper publications.
lots of studies in the past 4 years on the topic of targeted delivery in dermatological diseases.
one study from2020 used dutasteride in a pig study with a Franz diffusion cells, they showed now transdermal flux(into deeper layers of the skin or "past" the skin) while having 7 times the accumulation right in the follicle (around the dermal papilla and bulb, directly where dht acts) compared to other carrier. they used some super advanced ion metallic nanoparticles to encapsulate it there. the particle had an affinity primarily for the hair follicle entrance. study: ( https://www.sciencedirect.com/science/article/pii/S0378517320306931 )
indeed we want something like this https://ars.els-cdn.com/content/image/1-s2.0-S0378517320306931-gr6.jpg where there is increased concentration of the carrier primarily in the follicle as opposed to other parts of the skin. while this alone does not limit how much goes systemic, it allows using a much smaller dose due to increased targeting.
despite that I dont think there will be any commercialization(maybe hutera). this is something for the future though and targeted delivery of existing drugs is much more promising than all the new drugs bullshit that have the same up and downsides as existing ones
Imagine you can not tolerate 0.5% pyrilutamide, maybe you can tolerate 0.1%, get a good carrier for it that increases the local concentration around the follicle 5 times, has a slow release and suddenly you can get away with using 0.1% once a day opposed to 0.5% twice a day.
for more information on the major 3 different skin delivery pathways (https://www.researchgate.net/public...tes-for-a-molecule-to-cross-the-skin_W640.jpg) and the potential to deliver hair loss drugs directly to the follicle in higher amounts, refer to this review paper from 2022
what im saying is, liposomal is not the easy answer, a lot of thought must go into the design of such a delivery system. but technically I think it can be done and it is my opinion much more realistic than to get a good drug from big pharma that does not have the same negative properties like finasteride(pyrilutamide should be that drug and it didn't seem to deliver in terms of tolerability).
a nano carrier encapsulated pyril however might
Last edited:
RageAgainstTheMachine
New Member
- Reaction score
- 1
Do we actually know the binding affinity of Pyrilutamide? How stronger is it than dht and testosterone?